Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation studyIrina Bancos, Lorna C Gilligan, Giuseppe Reimondo et al.|The Lancet Diabetes & Endocrinology|2020Cited by 247
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort studyTimo Deutschbein, Marco Boscaro, Giuseppe Reimondo et al.|The Lancet Diabetes & Endocrinology|2022Cited by 180
Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized PrognosticationJuliane Lippert, Cristina L. Ronchi|The Journal of Clinical Endocrinology & Metabolism|2018Cited by 119
Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive FactorsJudith E K Henning, Cristina L. Ronchi|The Journal of Clinical Endocrinology & Metabolism|2017Cited by 90
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinomaKatia Mariniello, Leonardo Guasti, James Pittaway et al.|Cancer Communications|2025Cited by 6